I actualy think the EBITDA will be quite close to the forecast.
Remember 3.3m of expenses was for staff/board incentive payments for fy18-fy21.
You also need to remember revenue will be significantly higher then the forecast in this report as loan originations are significantly higher then forecast. They have already hit the amount forecast for Q1FY22 (81.6m). I would say revenue will be closer to 25m-27m for the year unlike the 22.5m forecast.
Loan originations will also start to grow as vaccines start to rollout and economy recovers more aggressively.
Lets see will be interesting. Still the fastest growing neo lender.
